Imec licenses Covid detection technology

Find the Latest SoC Solutions
for... Automotive... IoT... Security... Audio... Video

www.electronicsweekly.com, Oct. 19, 2021 – 

Imec and Imec spin-off miDiagnostics have signed a non-exclusive licensing agreement for Imec's patented technology whereby aerosols and droplets from exhaled breath are captured for screening for viral RNA through miDiagnostics ultrafast PCR technology.

The agreement enables miDiagnostics to kickstart the commercialization of a COVID-19 breathalyzer (as opposed to classical COVID-19 testing methods based on blood, saliva or a sample from the nose/throat cavity).

In the past year, Imec developed a breath sampler and performed clinical studies with the university hospital and university of Leuven showing that the breath sampler is capable of capturing the SARS-CoV-2 virus in exhaled air, and detecting the viral RNA quickly and reliably.

Also, Inec developed a sampling instrument integrating the breath sampling technology and imec's ultra-fast PCR-test, and optimized the robustness and ease of use, to achieve a functioning proof-of-concept to date.

click here to read more...

 Back